Stryker Profit Beats, But Hip and Knee Sales Weak

CHICAGO, April 19 (Reuters) - Stryker Corp (SYK.N) posted quarterly earnings on Tuesday above analysts’ expectations as strength in its surgical division and newly acquired neurovascular business offset weak hip and knee sales.

MORE ON THIS TOPIC